Header Logo

MARY MCKENNA

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address6621 FANNIN
vCardDownload vCard
    Other Positions
    TitleAssistant Professor
    InstitutionBaylor College of Medicine
    DepartmentCenter for Cell & Gene Therapy
    DivisionCenter for Cell & Gene Therapy


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chatterjee M, Gu F, Samanta S, Rasaily U, Thota SM, Varghese D, Qiu Y, Fordwuo LEE, Villanueva H, McKenna MK, Park JH, Zhang W, Tian L, Yu L, Piyarathna B, Gao Y, Simons BW, Jung SY, Karanam B, Putluri V, Chandandeep N, Mohamed N, Asirvatham JR, Jebakumar D, Rao A, Gutierrez C, Omilian AR, Morrison C, Das GM, Ambrosone C, Seeley EH, Kaipparettu BA, Kurland IJ, Putluri N, Elkhanany A, Davis AA, Zhu Q, Zhang XH, Sreekumar A. AADAT-Driven Metabolic Control of Malate and CoQ10 Shapes Immune Evasion in Triple-Negative Breast Cancer. bioRxiv. 2026 Jan 30. PMID: 41659489; PMCID: PMC12874059.
      Citations:    
    2. Van Pelt S, White M, Tat C, Hooper D, Talbot LJ, McKenna MK, Fernandes R, Rooney CM, Omer B, Van Pelt S, White M, Tat C, Hooper D, Talbot LJ, McKenna MK, Fernandes R, Rooney CM, Omer B. Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b. Cancer Immunol Res. 2025 Nov 03; 13(11):1732-1748. PMID: 40889278.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    3. Berger HR, Maharana M, Mirabal J, Kurenbekova L, Delaidelli A, Dasgupta A, Gad AZ, Sheha MF, Kerr SS, Ozcan AI, Morris JS, Major AM, Hicks MJ, McKenna MK, Seon BK, Baker ML, Sorensen PH, Hegde M, Yustein J, Ahmed N, Joseph SK, Berger HR, Maharana M, Mirabal J, Kurenbekova L, Delaidelli A, Dasgupta A, Gad AZ, Sheha MF, Kerr SS, Ozcan AI, Morris JS, Major AM, Hicks MJ, McKenna MK, Seon BK, Baker ML, Sorensen PH, Hegde M, Yustein JT, Ahmed N, Joseph SK. Endoglin-Directed CAR T Cells Comprehensively Target Tumors in Advanced Sarcomas. Cancer Immunol Res. 2025 Oct 01; 13(10):1591-1608. PMID: 40748238; PMCID: PMC12492877.
      Citations:    Fields:    Translation:HumansAnimalsCells
    4. Ozcan AI, L?pez AA, McKenna MK, Brenner MK, Thompson AM. Peritoneal Immunosurgery: Immunotherapy Augmented Surgery for the Treatment of Peritoneal Cancers. J Surg Oncol. 2025 Oct; 132(5):789-809. PMID: 40958736; PMCID: PMC12501933.
      Citations: 1     Fields:    Translation:Humans
    5. Torres Chavez AG, McKenna MK, Gupta A, Daga N, Vera J, Leen AM, Bajgain P. IL-7 armed binary CAR T cell strategy to augment potency against solid tumors. Front Immunol. 2025; 16:1618404. PMID: 40808942; PMCID: PMC12343627.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    6. Chavez AGT, McKenna MK, Gupta A, Daga N, Vera J, Leen AM, Bajgain P. IL-7 armed binary CAR T cell strategy to augment potency against solid tumors. bioRxiv. 2025 Jun 27. PMID: 40667190; PMCID: PMC12262363.
      Citations:    
    7. Kleinerova J, Tahedl M, McKenna MC, Garcia-Gallardo A, Hutchinson S, Hardiman O, Raoul C, Ango F, Schneider B, Pradat PF, Tan EL, Bede P. Cerebellar dysfunction in frontotemporal dementia: intra-cerebellar pathology and cerebellar network degeneration. J Neurol. 2025 Mar 25; 272(4):289. PMID: 40131525; PMCID: PMC11937067.
      Citations: 4     Fields:    Translation:Humans
    8. ?zcan AI, Aquino L?pez A, Wolff AN, Ma A, Shaw AR, Suzuki M, Brenner MK, McKenna MK. Mesenchymal stromal cells protect combined oncolytic and helper-dependent adenoviruses from humoral immunity. Mol Ther Methods Clin Dev. 2024 Sep 12; 32(3):101279. PMID: 38993326; PMCID: PMC11238183.
      Citations:    
    9. Dienel GA, Schousboe A, McKenna MC, Rothman DL. A tribute to Leif Hertz: The historical context of his pioneering studies of the roles of astrocytes in brain energy metabolism, neurotransmission, cognitive functions, and pharmacology identifies important, unresolved topics for future studies. J Neurochem. 2024 05; 168(5):461-495. PMID: 36928655.
      Citations:    
    10. McKenna MK, Ozcan A, Brenner D, Watanabe N, Legendre M, Thomas DG, Ashwood C, Cummings RD, Bonifant C, Markovitz DM, Brenner MK. Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma. J Immunother Cancer. 2023 01; 11(1). PMID: 36653070; PMCID: PMC9853244.
      Citations:    Fields:    Translation:HumansAnimalsCells
    11. Watanabe N, Mo F, McKenna MK. Impact of Manufacturing Procedures on CAR T Cell Functionality. Front Immunol. 2022; 13:876339. PMID: 35493513; PMCID: PMC9043864.
      Citations: 1     Fields:    Translation:HumansCells
    12. Waddell J, McKenna MC, Kristian T. Brain ethanol metabolism and mitochondria. Curr Top Biochem Res. 2022; 23:1-13. PMID: 36873619; PMCID: PMC9980429.
      Citations:    
    13. Atilla PA, McKenna MK, Watanabe N, Mamonkin M, Brenner MK, Atilla E. Combinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancy. Cytotherapy. 2022 03; 24(3):282-290. PMID: 34955406; PMCID: PMC8950815.
      Citations:    Fields:    Translation:AnimalsCellsCTClinical Trials
    14. Nalawade SA, Shafer P, Bajgain P, McKenna MK, Ali A, Kelly L, Joubert J, Gottschalk S, Watanabe N, Leen A, Parihar R, Vera Valdes JF, Hoyos V. Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer. J Immunother Cancer. 2021 11; 9(11). PMID: 34815355; PMCID: PMC8611441.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    15. Kristian T, Karimi AJ, Fearnow A, Waddell J, McKenna MC. Perturbed Brain Glucose Metabolism Caused by Absent SIRT3 Activity. Cells. 2021 09 08; 10(9). PMID: 34571997; PMCID: PMC8469836.
      Citations:    
    16. Watanabe N, McKenna MK. Generation of CAR T-cells using ?-retroviral vector. Methods Cell Biol. 2022; 167:171-183. PMID: 35152995; PMCID: PMC8917789.
      Citations: 1     Fields:    Translation:Cells
    17. Rosewell Shaw A, Porter CE, Yip T, Mah WC, McKenna MK, Dysthe M, Jung Y, Parihar R, Brenner MK, Suzuki M. Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors. Commun Biol. 2021 03 19; 4(1):368. PMID: 33742099; PMCID: PMC7979740.
      Citations: 7     Translation:HumansCells
    18. McKenna MK, Englisch A, Brenner B, Smith T, Hoyos V, Suzuki M, Brenner MK. Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity. Mol Ther. 2021 05 05; 29(5):1808-1820. PMID: 33571680; PMCID: PMC8116608.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    19. Watanabe N, McKenna MK, Rosewell Shaw A, Suzuki M. Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment. Mol Ther. 2021 02 03; 29(2):505-520. PMID: 33130314; PMCID: PMC7854303.
      Citations: 8     Fields:    Translation:HumansCells
    20. Ataca Atilla P, McKenna MK, Tashiro H, Srinivasan M, Mo F, Watanabe N, Simons BW, McLean Stevens A, Redell MS, Heslop HE, Mamonkin M, Brenner MK, Atilla E. Modulating TNFa activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. J Immunother Cancer. 2020 09; 8(2). PMID: 32938629; PMCID: PMC7497527.
      Citations: 44     Fields:    Translation:HumansAnimalsCells
    21. Mo F, Watanabe N, McKenna MK, Hicks MJ, Srinivasan M, Gomes-Silva D, Atilla E, Smith T, Ataca Atilla P, Ma R, Quach D, Heslop HE, Brenner MK, Mamonkin M. Engineered off-the-shelf therapeutic T cells resist host immune rejection. Nat Biotechnol. 2021 01; 39(1):56-63. PMID: 32661440; PMCID: PMC7854790.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    22. McKenna MK, Rosewell-Shaw A, Suzuki M. Modeling the Efficacy of Oncolytic Adenoviruses In Vitro and In Vivo: Current and Future Perspectives. Cancers (Basel). 2020 Mar 07; 12(3). PMID: 32155969; PMCID: PMC7139921.
      Citations: 4     
    23. Torres Chavez A, McKenna MK, Canestrari E, Dann CT, Ramos CA, Lulla P, Leen AM, Vera JF, Watanabe N. Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity. J Immunother Cancer. 2019 11 28; 7(1):330. PMID: 31779709; PMCID: PMC6883585.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    MCKENNA's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (112)
    Explore
    _
    Co-Authors (34)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _